MIF and viral myocarditis: Treatment of these mice with an anti-MIF antibody increased survival, decreased disease severity, and decreased IL-1β and TNF-α in the myocardium (113), suggesting MIF inhibition as a viable treatment option for dampening the inflammatory response in viral myocarditis.